(Total Views: 539)
Posted On: 05/01/2020 2:09:31 PM
Post# of 154098
Somewhat of a rhetorical question:
Is there any version of reality where the FDA grants early approval for leronlimab for reasons that are similar to their illogical approval of remdesivir?
In other words, is the administration so desperate to get the US back to work, and allaying the fears of the general public, that the FDA relaxes the approval process and grants approval for leronlimab (based on its efficacy and safety profile)?
And, is the possibility of that outcome possibly why Dr. NP was smiling?
Is there any version of reality where the FDA grants early approval for leronlimab for reasons that are similar to their illogical approval of remdesivir?
In other words, is the administration so desperate to get the US back to work, and allaying the fears of the general public, that the FDA relaxes the approval process and grants approval for leronlimab (based on its efficacy and safety profile)?
And, is the possibility of that outcome possibly why Dr. NP was smiling?
(0)
(0)
